318 related articles for article (PubMed ID: 26136118)
1. Identification of the first large deletion in the CLDN16 gene in a patient with FHHNC and late-onset of chronic kidney disease: case report.
Yamaguti PM; dos Santos PA; Leal BS; Santana VB; Mazzeu JF; Acevedo AC; Neves Fde A
BMC Nephrol; 2015 Jul; 16():92. PubMed ID: 26136118
[TBL] [Abstract][Full Text] [Related]
2. First report of a novel missense CLDN19 mutations causing familial hypomagnesemia with hypercalciuria and nephrocalcinosis in a Chinese family.
Yuan T; Pang Q; Xing X; Wang X; Li Y; Li J; Wu X; Li M; Wang O; Jiang Y; Dong J; Xia W
Calcif Tissue Int; 2015 Apr; 96(4):265-73. PubMed ID: 25555744
[TBL] [Abstract][Full Text] [Related]
3. Familial hypomagnesemia with hypercalciuria and nephrocalcinosis: unusual clinical associations and novel claudin16 mutation in an Egyptian family.
Al-Haggar M; Bakr A; Tajima T; Fujieda K; Hammad A; Soliman O; Darwish A; Al-Said A; Yahia S; Abdel-Hady D
Clin Exp Nephrol; 2009 Aug; 13(4):288-294. PubMed ID: 19165416
[TBL] [Abstract][Full Text] [Related]
4. Hypomagnesemia with Hypercalciuria Leading to Nephrocalcinosis, Amelogenesis Imperfecta, and Short Stature in a Child Carrying a Homozygous Deletion in the CLDN16 Gene.
Radonsky V; Kizys MML; Dotto RP; Esper PLG; Heilberg IP; Dias-da-Silva MR; Lazaretti-Castro M
Calcif Tissue Int; 2020 Oct; 107(4):403-408. PubMed ID: 32710267
[TBL] [Abstract][Full Text] [Related]
5. Novel compound heterozygous mutations of CLDN16 in a patient with familial hypomagnesemia with hypercalciuria and nephrocalcinosis.
García-Castaño A; Perdomo-Ramirez A; Vall-Palomar M; Ramos-Trujillo E; Madariaga L; Ariceta G; Claverie-Martin F
Mol Genet Genomic Med; 2020 Nov; 8(11):e1475. PubMed ID: 32869508
[TBL] [Abstract][Full Text] [Related]
6. Characterization of two novel mutations in the claudin-16 and claudin-19 genes that cause familial hypomagnesemia with hypercalciuria and nephrocalcinosis.
Perdomo-Ramirez A; Aguirre M; Davitaia T; Ariceta G; Ramos-Trujillo E; ; Claverie-Martin F
Gene; 2019 Mar; 689():227-234. PubMed ID: 30576809
[TBL] [Abstract][Full Text] [Related]
7. Familial hypomagnesemia with hypercalciuria and nephrocalcinosis: phenotype-genotype correlation and outcome in 32 patients with CLDN16 or CLDN19 mutations.
Godron A; Harambat J; Boccio V; Mensire A; May A; Rigothier C; Couzi L; Barrou B; Godin M; Chauveau D; Faguer S; Vallet M; Cochat P; Eckart P; Guest G; Guigonis V; Houillier P; Blanchard A; Jeunemaitre X; Vargas-Poussou R
Clin J Am Soc Nephrol; 2012 May; 7(5):801-9. PubMed ID: 22422540
[TBL] [Abstract][Full Text] [Related]
8. Mutation in the tight-junction gene claudin 19 (CLDN19) and familial hypomagnesemia, hypercalciuria, nephrocalcinosis (FHHNC) and severe ocular disease.
Naeem M; Hussain S; Akhtar N
Am J Nephrol; 2011; 34(3):241-8. PubMed ID: 21791920
[TBL] [Abstract][Full Text] [Related]
9. Familial hypomagnesemia with hypercalciuria and nephrocalcinosis associated with CLDN16 mutations.
Kang JH; Choi HJ; Cho HY; Lee JH; Ha IS; Cheong HI; Choi Y
Pediatr Nephrol; 2005 Oct; 20(10):1490-3. PubMed ID: 16047219
[TBL] [Abstract][Full Text] [Related]
10. Claudin-19 mutations and clinical phenotype in Spanish patients with familial hypomagnesemia with hypercalciuria and nephrocalcinosis.
Claverie-Martín F; García-Nieto V; Loris C; Ariceta G; Nadal I; Espinosa L; Fernández-Maseda Á; Antón-Gamero M; Avila A; Madrid Á; González-Acosta H; Córdoba-Lanus E; Santos F; Gil-Calvo M; Espino M; García-Martinez E; Sanchez A; Muley R;
PLoS One; 2013; 8(1):e53151. PubMed ID: 23301036
[TBL] [Abstract][Full Text] [Related]
11. Familial hypomagnesemia with hypercalciuria and nephrocalcinosis.
Vall-Palomar M; Madariaga L; Ariceta G
Pediatr Nephrol; 2021 Oct; 36(10):3045-3055. PubMed ID: 33595712
[TBL] [Abstract][Full Text] [Related]
12. Hypomagnesemia-hypercalciuria-nephrocalcinosis and ocular findings: a new claudin-19 mutation.
Ekinci Z; Karabaş L; Konrad M
Turk J Pediatr; 2012; 54(2):168-70. PubMed ID: 22734304
[TBL] [Abstract][Full Text] [Related]
13. Familial hypomagnesemia with hypercalciuria and nephrocalcinosis: variable phenotypic expression in three affected sisters from Mexican ancestry.
Arteaga ME; Hunziker W; Teo AS; Hillmer AM; Mutchinick OM
Ren Fail; 2015 Feb; 37(1):180-3. PubMed ID: 25366522
[TBL] [Abstract][Full Text] [Related]
14. Familial hypomagnesemia with hypercalciuria and nephrocalcinosis (FHHNC): report of three cases with a novel mutation in CLDN19 gene.
Al-Shibli A; Konrad M; Altay W; Al Masri O; Al-Gazali L; Al Attrach I
Saudi J Kidney Dis Transpl; 2013 Mar; 24(2):338-44. PubMed ID: 23538362
[TBL] [Abstract][Full Text] [Related]
15. Claudin 19-based familial hypomagnesemia with hypercalciuria and nephrocalcinosis in a sibling pair.
Sharma S; Place E; Lord K; Leroy BP; Falk MJ; Pradhan M
Clin Nephrol; 2016 Jun; 85(6):346-52. PubMed ID: 27007868
[TBL] [Abstract][Full Text] [Related]
16. Unusual clinical presentation and possible rescue of a novel claudin-16 mutation.
Müller D; Kausalya PJ; Bockenhauer D; Thumfart J; Meij IC; Dillon MJ; van't Hoff W; Hunziker W
J Clin Endocrinol Metab; 2006 Aug; 91(8):3076-9. PubMed ID: 16705067
[TBL] [Abstract][Full Text] [Related]
17. Familial Hypomagnesemia with Hypercalciuria and Nephrocalcinosis Due to CLDN16 Gene Mutations: Novel Findings in Two Cases with Diverse Clinical Features.
Eltan M; Yavas Abali Z; Turkyilmaz A; Gokce I; Abali S; Alavanda C; Arman A; Kirkgoz T; Guran T; Hatun S; Bereket A; Turan S
Calcif Tissue Int; 2022 Apr; 110(4):441-450. PubMed ID: 34761296
[TBL] [Abstract][Full Text] [Related]
18. A novel mutation in CLDN16 results in rare familial hypomagnesaemia with hypercalciuria and nephrocalcinosis in a Chinese family.
Lv F; Xu XJ; Wang JY; Liu Y; Jiang Y; Wang O; Xia WB; Xing XP; Li M
Clin Chim Acta; 2016 Jun; 457():69-74. PubMed ID: 27067446
[TBL] [Abstract][Full Text] [Related]
19. Two heterozygous mutations of CLDN16 in a Japanese patient with FHHNC.
Tajima T; Nakae J; Fujieda K
Pediatr Nephrol; 2003 Dec; 18(12):1280-2. PubMed ID: 14586675
[TBL] [Abstract][Full Text] [Related]
20. Exonic CLDN16 mutations associated with familial hypomagnesemia with hypercalciuria and nephrocalcinosis can induce deleterious mRNA alterations.
Perdomo-Ramirez A; de Armas-Ortiz M; Ramos-Trujillo E; Suarez-Artiles L; Claverie-Martin F
BMC Med Genet; 2019 Jan; 20(1):6. PubMed ID: 30621608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
